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Abstract
Age-related hearing loss (ARHL) is a prevalent communication problem among senior
citizens. Previous work (Tadros et al., 2008) has revealed genes which change their
expression significantly with aging and hearing loss. However, this study is limited as it
mainly focuses on apoptosis-related genes. Genes that regulate biological pathways other
than apoptosis might also contribute to the development of age-related hearing loss, as
suggested by some studies (Tadros et al., 2007; Souza et al., 2008). In order to
circumvent this limitation and to better understand the underlying mechanisms of this
communication problem, a free computational tool called Gene Set Enrichment Analysis
(GSEA) is used to analyze the microarray data of aging cochlea and brain. Results show
that most of the pathways which are up-regulated with aging/hearing loss in cochlea play
a role in apoptosis and/or inflammation, suggesting that these two processes might be
crucial for the development of ARHL. In contrast to the results from the cochlea, results
for the aging brain indicate that cell cycle arrest is involved in deficits in the central
auditory system with age.

Keyword: Age-related hearing loss, Gene Set Enrichment Analysis, Apoptosis,
Cochlea, Auditory Midbrain, Microarrays
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1. Introduction
1.1 Age-related Hearing Loss
In humans, age-related hearing loss (ARHL), or presbycusis, is a prevalent
communication problem among senior citizens. It compromises the health of elderly
persons and reduces the quality of their daily life, as it not only results in auditory
deficiency, but also has psychological, physical and social consequences [1]. With the
increased number of elderly people in our society, both in relative and absolute numbers,
developing therapeutic treatments for ARHL becomes even more important, particularly
in terms of reducing the load on our over-burdened health care system. As the therapeutic
treatment of disease can be based on the understanding of the underlying cellular and
molecular mechanisms behind it, numerous studies which focus on the pathological and
physiological processes of ARHL have been conducted.

CBA/CaJ mice is often used as the model organism for the study of aging in the central
auditory system. After correcting for the differences in the lifespans of mice and men, it
shows a progressive hearing loss which is similar to presbycusis in humans (Frisina and
Walton, 2006).
1

1.2 The Cochlea
The cochlea, whose structure consists of the inner and the outer hair cells, their
supporting cells and the stria vascularis, is an important part of the auditory system in the
mouse and the human inner ear [4]. Studies show that structural changes of the cochlea
during the aging process lead to age-related hearing loss [1]. For example, it is often
noted that ARHL is consistently associated with a decline in the number of outer hair
cells and a smaller decrease in the numbers of inner hair cells [5]. Other lines of
investigation point to the pathology of the stria vascularis, the specialized cochlear organ
that produces endolymph, as a key component of ARHL (Schmiedt, 1996; Suryadevara et
al.,2001). Thus, study of the underlying biological changes that occur with age in the
cochlea is crucial to understanding the mechanisms of ARHL.

1.3 Apoptosis
1.3.1 Apoptosis and Age-related Hearing Loss
Study of ARHL is very difficult as it is an extremely complex system of processes
involving the participation of multiple cellular pathways which are influenced by a
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combination of different genetic and environmental factors [1]. It is highly speculated
that apoptosis, the endogenous programmed cell death, plays an important role in ARHL.

1.3.2 Biological Significance of Apoptosis
Apoptosis, described first by Kerr, Wyllie, and Currie in 1972, is a distinct form of cell
death which helps to maintain homeostasis in multi-cellular biological systems. It is of
great biological significance: on the one hand, appropriate apoptosis is the requirement
for the normal functioning of a wide variety of processes ranging from immune reactions,
embryonic development to hormone-dependent atrophy [6,7]; on the other hand,
dysfunction (or dysregulation) of apoptosis (either too little or too much) is associated
with a variety of human diseases. For example, insufficient apoptosis may result in
cancer, autoimmune diseases as well as spreading of viral infections. On the contrary,
excessive apoptosis is thought to play a role in AIDS, ischaemic disease and
neurodegenerative disorders like Parkinson’s and Alzheimer’s Disease [7,8].

1.3.3 Intracellular Morphological Features of Apoptosis
Cells undergo apoptosis following a series of controlled steps which eventually leads to
cellular self-destruction in response to stimuli such as heat, radiation, hypoxia and
3

cytotoxic anticancer drugs [6,7]. The morphological changes of apoptosis include cell
shrinkage (which is characterized by smaller cell size, dense cytoplasm and more tightly
packed organelles), pyknosis (which results from chromatin condensation), karyorrhexis
(fragmented nuclei), the plasma membrane blebbing and budding [4,6].

1.3.4 Apoptosis and Necrosis
Unlike necrosis, the unintentional form of cell death in which case inflammatory
reactions are caused by the release of the cytoplasmic contents into the surrounding tissue
as a result of disrupted cell membrane, the process of apoptosis is controlled in such a
way that essentially, there is no inflammatory reaction associated with it nor does it cause
damage to its surrounding cells [6,7]. This is largely due to the fact that apoptotic cells,
which are quickly phagocytosed by macrophages or neighboring cells, do not release
their cellular constituents into the adjacent tissues [6].

As different as necrosis and apoptosis are in their mechanisms, they are still closely
connected to each other as they share morphological features and biological networks in
common. Although both necrosis and apoptosis can be induced by similar stimuli, which
one is going to be induced in cells depends largely on the degree and nature of the stimuli
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[6]. Interestingly, there is even evidence indicating that an ongoing apoptotic process can
be converted into a necrotic process under certain conditions [9,10].

1.3.5 Mechanisms of Apoptosis
Apoptosis is an extremely complex and sophisticated process. Generally, there are two
types of apoptotic pathways: extrinsic (or death receptor) pathway and intrinsic (or
mitochondrial) pathway. They converge at the final stage of apoptosis, named the
execution phase, which starts with the activation of caspases [6].

1.3.5.1 Extrinsic Pathway
The extrinsic pathway is caused by the binding of specific ligands called pro-apoptotic
ligands (such as Fas, TNF alpha and TRAIL) with death receptors that are located on the
cell surface. Following ligand binding, receptors cluster and undergo the conformational
changes. This induces a death domain and allows the recruitment of adaptor proteins such
as Fas-associated death domain protein (FADD) or TNF-receptor associated death
domain protein (TRADD) [8]. It then results in the formation of the protein complex,
death inducing signal complex (DISC) and the recruitment of caspase 8. After caspase 8
is activated, the execution phase of apoptosis is initiated.

5

Pro-apoptotic ligand + Death receptor

DISC

CASP 8

Execution Phase
Figure 1. Extrinsic pathway of apoptosis

1.3.5.2 Intrinsic Pathway
The intrinsic pathway can be initiated by stimuli that act either negatively (withdrawal of
cell survival signal, absence of certain growth factors) or positively (radiation, toxins,
hypoxia, hyperthermia, viral infection, free radicals) inside the cells [6]. Upon
stimulation, the mitochondrial inner transmembrane potential is reduced and the
mitochondrial permeability transition (PT) pore is opened. This results in the release of
pro-apoptotic proteins such as cytochrome c from the mitochondrial intermembrane space
into the cytosol [6]. After that, cytochrome c binds the adaptor apoptotic protease
activating factor-1 (Apaf-1) and procaspase-9, leading to the formation of a large multi-
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protein complex called “apoptosome” which then causes the activation of caspase 9 and
initiation of execution phase [6,8].

The intrinsic apoptosis pathway is regulated by the B-cell lymphoma 2 (Bcl-2) family of
proteins which can be divided into two groups: pro-apoptotic and anti-apoptotic proteins.
Pro-apoptotic proteins such as Bad, Bax and Bid tend to induce apoptosis while antiapoptotic proteins such as Bcl-2, Bcl-X tend to resist to apoptosis [8]. Whether apoptosis
will be activated or not is determined by the ratio of the two types of proteins [8].

Mitochondrial

Cytochrome C

Apaf-1

Procasp-9

apoptosome
e

Casp-9

Execution Phase
Figure 2. Intrinsic pathway of apoptosis
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1.3.5.3 Execution Phase
Caspases, a family of proteins belonging to a group of enzymes known as cysteine
proteases are the central executors and mediators of the execution phase of apoptosis [8].
There are two types of caspases: initiator caspases and effector (or executor) caspases
which stay inactive within cells until being activated. Initiator caspases such as Caspase2,8,9,10 which reside upstream in the pathway and are activated by the induction of
either extrinsic pathways or intrinsic pathways or both, will in turn, activate downstream
effector caspases such as Caspase-3,6,7. The activation of effector caspases, then leads to
the cleavage of key cellular proteins such as cytoskeletal proteins, and this accounts for
the morphological changes observed in cells undergoing apoptosis [8].

Pro-apoptotic stimulus

Initiator caspases

Effector caspases

Apoptosis
Figure 3. Execution phase of apoptosis
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2. Data and Methods
2.1 Description of the Mouse Cochlea and Brain
Microarray Data
Data used in this study are microarray mouse gene expression data from the cochlea and
the inferior colliculus which are provided by Dr. Frisina’s Lab. CBA/CaJ mice were used
as the model organism for this study as this strain shows a progressive hearing loss that
parallels that of presbycusis in humans, when accounting for the lifespan of each species
(Frisina and Walton, 2006). Based on age and functional hearing measurements obtained
from the auditory brainstem response recordings (ABR thresholds) and the otoacoustic
emissions (DPOAE amplitudes), the whole sample set can be divided into four groups:
young adult control with good hearing, middle-aged with good hearing, old with mild
presbycusis and old with severe presbycusis [4]. One Affymetrix M430A high-density
oligonucleotide array set containing 22,600 probe sets which analyze the expression of
over 14,000 mouse genes was used for each sample [4]. Full experimental details can be
found in Sherif F. Tadros, Mary D’Souza, Xiaoxia Zhu, Robert D. Frisina’s paper:
Apoptosis-related genes change their expression with age and hearing loss in the mouse
cochlea, Apoptosis (2008) [4].
9

2.2 Data Normalization
The goal of high density oligonucleotide arrays is to detect differences of mRNA
expression in response to genetic and environmental differences, which is also referred to
as interesting variation [14]. However, non-biologically originated variations, also known
as obscuring variations (or systematic variations) which are introduced during sample
preparation, manufacture of the arrays, and the processing of the arrays (labeling,
hybridization, and scanning) also exist and could mislead interpretation of the results [14].
Thus, before proceeding with a formal statistical analysis, obscuring variations should be
reduced first by applying preprocessing steps such as data normalization. In this study,
data is normalized by implementing the Robust Multi-array Average (RMA) method of
Affymetrix

Oligonucleotide

Arrays

R

package,

which

is

freely

available

(http://www.bioconductor.org). RMA is a normalization method which consists of three
preprocessing steps: background correction, quantile normalization and a final
summarization. It has been shown by other studies (Irizarry et al. 2003) that RMA
outperformed AvDiff, the Li and Wong model-based expression index, dChip and MAS
5.0 in the following aspects: first of all, RMA shows higher precision without
compromising its accuracy; second, estimations of fold change provided by RMA are
10

more consistent; third, results provided by RMA shows higher specificity and sensitivity,
when using fold change analysis to detect differential expression patterns [12,14].

2.3 GSEA
2.3.1

Advantages Using GSEA

Gene Set Enrichment Analysis (GSEA) is a powerful analytical method for the
interpretation of gene expression data and is incorporated into a software package that
can be downloaded freely (http://www.broadinstitute.org/gsea). Traditional single gene
analysis such as ANOVA, although useful, is limited by its low overlapping rate between
different studies, its failure to capture significant genes with unifying biological themes
as well as its deficiency to reveal underlying relationships between those genes. GSEA is
designed to circumvent such limitations by analyzing gene expression data at the level of
gene sets.

2.3.2

Overview

Based on gene sets which are defined based upon prior biological knowledge, such as
published information about biochemical pathways or co-expression patterns in previous
experiments and samples that fall into two classes, GSEA tries to find gene sets that are
11

associated with one of the two classes by determining whether the members of a gene set
tend to occur toward the top (or bottom) of the class list [15].

2.3.3

Methods

There are three steps for the GSEA method. In the first step, an Enrichment Score (ES) is
calculated to measure how well a given gene set is overrepresented towards the top or
bottom of the entire ranked list. Then, the nominal P value which reflects the statistical
significance of the ES is estimated using a phenotype-based permutation test. In the last
step, ES is normalized to account for the size of each gene set, resulting in normalized
enrichment score (NES) [16]. A false discovery rate (FDR) is also calculated with NES
correspondingly.

2.3.4

Leading Edge Analysis

Even in gene sets with high ES, not all their members are up-regulated. Leading edge
analysis is designed to find out the leading edge subset, a subset of genes that contribute
most to the ES within a high scoring gene set [15]. Leading edge analysis might also
help to reveal gene sets with the same biological function on the basis of common leading
edge subsets that are shared by those high scoring gene sets.
12

2.3.5

Evaluation of Performances

In order to evaluate the performance of GSEA, several studies have been conducted (A.
Subramanian et al., 2003). In the first study (Male vs. Female Lymphoblastoid Cells),
gene sets on chromosome Y are found to be up-regulated in male samples as expected.
Alternatively, X inactivation genes and female reproductive tissue expressed genes are
found to be up-regulated in female samples. Results of two other studies analyzed by
GSEA (p53 Status in Cancer Cell Lines and Acute Leukemias) are also biologically
meaningful. In the last study, two lung cancer gene expression data sets obtained
independently by different study groups (Boston group and Michigan group) are analyzed
with GSEA as well as single gene analysis and their results are also compared. The study
shows that similarities between results analyzed with GSEA of the two data sets are
significantly higher than those analyzed with single gene analysis. Thus, it can be
concluded that GSEA is superior to single gene analysis in both its reproducibility and
interpretability [15].
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2.3.6

Molecular Signature Database (MSigDB) and Biocarta

Since the performance of GSEA depends largely on how representative the given gene
sets are to the actual biological processes, the definition and curation of such gene sets
are of great significance [16]. Molecular Signature Database (MSigDB) which contains a
collection of gene sets has been created on the GSEA website to assist its users. Gene
sets can be generally divided into five categories: C1 positional gene sets which represent
genes in the same chromosome or cytogenetic band; C2 curated gene sets which originate
from publicly available databases of metabolic and signaling pathways such as KEGG,
BioCarta and PubMed; C3 motif gene sets which are based on conserved regulatory
motifs from comparative analysis of different species; C4 computational gene sets which
is defined as sets of genes in expression neighborhoods of cancer-related genes; C5 GO
gene sets which consist of genes annotated by the same GO terms (Subramanian, Tamayo,
et al., 2005) [16]. The choice of specific gene sets should be based on data type and the
goal of the study.

BioCarta, one of the C2 curated gene sets, is selected as the database for gene sets in this
study. It seems to be the most appropriate choice for the present investigation, since it

14

maintains a good collection and classification of cellular pathways, including pathways
that are involved in apoptosis, cell cycle regulation, metabolism and immunology.
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3. Results
Since both old mice with mild presbycusis and old mice with severe presbycusis had a
small sample size in the gene microarray data set of the present study, they are combined
together as a single “old mice group” in order to have sufficient statistical power to carry
out the study. Comparisons such as young mice versus old mice and middle-aged mice
versus old mice are conducted using GSEA for both cochlea and brain gene microarray
data. Leading edge analysis is then conducted for gene sets that are significantly upregulated in old mice.
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3.1 GSEA Result for Cochlear Data
The result of GSEA analysis for young mice versus old mice can be found in Table 1.
Ten pathways are found to be significantly up-regulated in old mice (NOM p value <
0.05, FDR < 0.3): Toll-Like Receptor Pathway (TOLL), Signal transduction through
IL1R (IL1R), TNFR1 Signaling Pathway (TNFR1), Signaling of Hepatocyte Growth
Factor Receptor (MET), NF-kB Signaling Pathway (NF-kB), TNFR2 Signaling Pathway
(TNFR2), TNF/Stress Related Signaling (Stress), FAS Signaling Pathway (CD95),
Inhibition of Cellular Proliferation by Gleevec (GLEEVEC) and Induction of apoptosis
through DR3 and DR4/5 Death Receptors (DEATH).
Symbol
TOLL
IL1R
TNFR1
MET

NOM p-value
0.002
0.002
0.023
0.008

FDR q-value
0.040
0.034
0.147
0.240

Pathway Description
Toll-Like Receptor Pathway
Signal transduction through IL1R
TNFR1 Signaling Pathway
Signaling of Hepatocyte Growth Factor
Receptor
NFKB
0.022
0.238
NF-kB Signaling Pathway
TNFR2
0.010
0.225
TNFR2 Signaling Pathway
STRESS
0.029
0.258
TNF/Stress Related Signaling
FAS
0.024
0.282
FAS Signaling Pathway (CD95)
GLEEVEC 0.022
0.250
Inhibition of Cellular Proliferation by
Gleevec
DEATH
0.049
0.284
Induction of apoptosis through DR3 and
DR4/5 Death Receptors
Table 1. Gene sets that are up-regulated in old mice (p < 0.05, FDR < 0.3). Comparisons
are conducted between young mice and old mice for the cochlear data.
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From these results, it can be inferred that most of the pathways which are found to be upregulated in old mice are closely connected with each other and fall into two major
groups: Toll/IL-1R and TNF super-family related pathways.

9
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Figure 4. Leading edge analysis for the ten gene sets in Table 1.
Leading edge analysis is conducted for the ten gene sets in Table 1. Genes that appear at
least twice are shown in Figure 4. Complete result for this analysis can be found in
Appendix. Genes such as MAP3K1, JUN, CFLAR are well known apoptosis genes and
showed significant gene expression differences in previous study (Tadros et al., 2008).
TRADD and CRADD are also apoptosis-related. Although not found by previous study,
they are statistically significant according to the result of this leading edge analysis.
NFKB1, IL1R1 are genes that involved in inflammation and innate immunity.
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Symbol
NOM p-value
INTRINSIC 0.000

FDR q-value
0.012

Pathway Description
Intrinsic
Prothrombin
Activation
Pathway
IL6
0.004
0.103
IL 6 signaling pathway
TOLL
0.010
0.154
Toll-Like Receptor Pathway
NKT
0.024
0.166
Selective expression of chemokine
receptors during T-cell polarization
IL2RB
0.008
0.145
IL-2 Receptor Beta Chain in T cell
Activation
IL12
0.027
0.130
IL12 and Stat4 Dependent Signaling
Pathway in Th1 Development
IL2
0.024
0.169
IL2 Signaling Pathway
NGF
0.030
0.276
Nerve growth factor pathway (NGF)
EPO
0.043
0.271
EPO Signaling Pathway
MET
0.031
0.246
Signaling of Hepatocyte Growth Factor
Receptor
Table 2. Gene sets that are up-regulated in old mice (p < 0.05, FDR < 0.3). Comparisons
are conducted between middle-aged mice with good hearing and old mice from cochlea
data.
The result of GSEA analysis for middle-aged mice with good hearing and old mice can
be found in Table 2. Ten pathways are found to be significantly up-regulated in old mice
(NOM p value < 0.05, FDR < 0.3): Intrinsic Prothrombin Activation Pathway
(INTRINSIC), IL 6 signaling pathway (IL6), Toll-Like Receptor Pathway (TOLL),
Selective expression of chemokine receptors during T-cell polarization (NKT), IL-2
Receptor Beta Chain in T cell Activation (IL2RB), IL12 and Stat4 Dependent Signaling
Pathway in Th1 Development (IL12), IL2 Signaling Pathway (IL2), Nerve growth factor
pathway (NGF), EPO Signaling Pathway (EPO), Signaling of Hepatocyte Growth Factor
Receptor (MET).
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Figure 5. Leading edge analysis for the ten gene sets in Table 2.
Leading edge analysis is conducted for the ten gene sets in Table 2. Genes that appear at
least twice are shown in Figure 5. Complete result for this analysis can be found in
Appendix. Genes such as CXCR3, IL12A, IL12B, IL12RB2, IL18R1 and STAT3 are
involved in T-cell differentiation and the development of adaptive immune system.
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3.2 GSEA Result for Brain Data
Symbol
P53
NKCELLS

NOM p-value FDR q-value
0.000
0.050
0.004
0.042

Pathway Description
p53 Signaling Pathway
Ras-Independent pathway in NK cellmediated cytotoxicity
P38MAPK
0.004
0.032
p38 MAPK Signaling Pathway
AMI
0.004
0.043
Acute Myocardial Infarction
CSK
0.004
0.035
Activation of Csk by cAMP-dependent
Protein Kinase Inhibits Signaling
through the T Cell Receptor
ATM
0.020
0.136
ATM Signaling Pathway
NKT
0.030
0.140
Selective expression of chemokine
receptors during T-cell polarization
G2
0.033
0.161
Cell Cycle: G2/M Checkpoint
G1
0.043
0.210
Cell Cycle: G1/S Check Point
IL1R
0.049
0.189
Signal transduction through IL1R
P53HYPOXIA 0.027
0.178
Hypoxia and p53 in the Cardiovascular
system
RACCYCD
0.032
0.207
Influence of Ras and Rho proteins on
G1 to S Transition
Table 3. Gene sets that are up-regulated in old mice for brain (p < 0.05, FDR < 0.3).
Comparisons are conducted between middle-aged mice with good hearing and old mice
for gene microarray data from the central auditory system.
The same comparisons are conducted for brain data. For the comparison young mice
versus old mice, no individual gene set meets the threshold for statistical significance.
The result of GSEA analysis for middle-aged mice with good hearing versus old mice can
be found in Table 3. Twelve pathways are found to be significantly up-regulated in old
mice (NOM p value < 0.05, FDR < 0.3): p53 Signaling Pathway (P53), Ras-Independent
pathway in NK cell-mediated cytotoxicity (NKCELLS), p38 MAPK Signaling Pathway
(P38MAPK), Acute Myocardial Infarction (AMI), Activation of Csk by cAMP21

dependent Protein Kinase Inhibits Signaling through the T Cell Receptor (CSK), ATM
Signaling Pathway (ATM), Selective expression of chemokine receptors during T-cell
polarization (NKT), Cell Cycle: G2/M Checkpoint (G2), Cell Cycle: G1/S Check Point
(G1), Signal transduction through IL1R(IL1R), Hypoxia and p53 in the Cardiovascular
system (P53HYPOXIA), Influence of Ras and Rho proteins on G1 to S Transition
(RACCYCD).

P53, P53HYPOXIA, ATM and P38 MAPK are all closely associated with intrinsic
apoptosis pathways. G1, G2 and RACCYCD pathways are responsible for cell
proliferation.

Number of Gene Sets

7
6

5
4
3
2
1

0

Gene

Figure 6. Leading edge analysis for the twelve gene sets in Table 3.
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Leading edge analysis is conducted for the ten gene sets in Table 3. Genes that appear at
least twice are shown in Figure 6. Complete result for this analysis can be found in
Appendix. CDKN1A, ATM, TGFB2 and CHEK2 are involved in cell cycle arrest.

4. Discussion
4.1 Toll/IL-1R Pathway and Innate Immunity
Innate immunity is an evolutionarily conserved protective mechanism in multi-cellular
organisms that provides the first line of defense for the host against invading pathogens.
It is triggered upon recognition of pathogen-associated molecular patterns (PAMPs) such
as lipopolysaccharide (LPS) and bacterial lipoprotein (BLP) by pattern recognition
receptors such as Toll-like receptor (TLR) and interleukin-1 receptor (IL-1R) [22].
Although previously being considered to be non-specific, innate immunity is later proved
to have some specificity since it can not only detect infections, but is also capable of
recognizing the type of invading pathogens [22]. Furthermore, it is a pre-requisite for the
activation of acquired immunity [18].

Pathways that are pertinent to innate immunity include Toll-Like Receptor Pathway,
signal transduction through IL1R and nuclear factor-kB (NF-kB) Signaling Pathway.
23

NF-kB plays a vital role in host defense mechanisms and it can be induced upon
activation of Toll or IL-1R signaling pathways [20].

Although the extracellular domains of TLRs and IL-1Rs are significantly different, they
have highly similar cytoplasmic domains, which is known as Toll/interleukin (IL)-1
receptor domain (TIR domain) [19]. Toll-Like Receptor Pathway and IL-1R Pathway are
homologous transduction signaling pathways. Upon stimulation, Toll and IL-1R can
induce the nuclear factor kB (NF-kB) pathway through MyD88/IRAK/TRAF6 pathway
[20]. Myeloid differentiation factor 88 (MyD88) functions as the common mediator for
Toll/IL-1R inducing NF-kB and apoptosis initiated by TLR2 [21,23]. MyD88 contains an
N-terminal death domain and a C-terminal TIR domain [22]. The death domain interacts
with the death domain of IL-1R-associated kinase (IRAK) and the TIR domain combines
with the TIR domains of Toll and the IL-1R. IRAK is then activated, autophosphorylated [22]. After its disassociation from MyD88, it associates with another
adaptor protein, called tumor necrosis factor (TNF) receptor-associated factors 6 (TRAF6)
[22]. NF-kB pathways is activated after the phosphorylation of IkB protein by IKK
kinases [22]. However, MyD88 is not indispensible for the activation of NF-kB since NFkB can also be activated through a MyD88-independent pathway initiated by TLR3 and
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TLR4, the mechanism of which is not fully understood [20]. It is shown that this MyD88
independent signaling is mediated by a novel adaptor protein called TIR-domaincontaining adapter protein (TIRAP) (Janssens et al., 2002) [20]. MyD88 dependent and
independent pathways converge at the formation of the IKK complex (Akira et al., 2001)
[18].

TLRs

IL1Rs

MyD88
8
TIRAP
IRAK

FADD

TRAF6

CASP8

IKKs

Apoptosis

NF-kB

Figure 7. Toll/IL-1R signaling pathway leading to NF-kB and apoptosis initiated by
TLR2. MyD88 works as the central mediator.
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It is reported that the apoptotic signaling pathway can be activated by TLR2 via
MyD88/FADD/Caspase 8 pathway (Aliprantis et al., 2000) [23]. FADD interacts with
MyD88 through their death domains (DDs) [20]. FADD can then bind with pro-caspase 8,
resulting in oligomerization, enzyme maturation and activation of apoptosis (Martin et al.,
1998; Muzio et al., 1998b) [23]. Although involvement of IL-1 in apoptosis has been
reported in diabetes mellitus (Sjoholm, 1998) and acute neurodegeneration (Rothwell et
al.,1997), it is still not clear whether IL-1 mediates cell death through the
MyD88/FADD/caspase 8 pathway [23]

4.2 NF-kB, Inflammation and Apoptosis
NF-kB signaling is the master regulator of inflammation. Before activated, NF-kB
complexes bind to the inhibitory IkB proteins and stay in the cytoplasm [37]. Once
stimulated, IkB proteins are phosphorylated and the NF-kB complex is translocated to
the nucleus [37]. This leads to the activation of genes which are responsible for the
induction of inflammation.

NF-kB signaling also can have anti-apoptotic actions in several ways [20,23]. First of all,
inhibitors of apoptosis (IAPs) such as c-FLIP, Bcl-xL, c-IAP1, c-IAP2 and XIAP are
activated by NF-kB signaling [37]. Furthermore, c-Jun N-terminal kinase (JNK), a well26

known kinase mediating apoptotic signals, can also be inhibited by NF-kB [37]. However,
NF-kB has also been implicated to promote pro-apoptotic responses and induce cell death
in some cell types (Baichwal and Baeuerle, 1997) [23].

NF-kB
IkB
IKKs

Cytoplasm
NF-kB

Nucleus

IAPs

JNK

Apoptosis

Figure 8. NF-kB inhibit apoptosis

27

4.3 TNF Superfamily, Induction of Apoptosis and NF-kB
Members of the TNF superfamily are known for their ability to regulate apoptosis, cell
proliferation, survival and differentiation [24]. The existence of as many as 30 members
of the TNF receptor superfamily has been revealed to date. Interestingly, it is shown that
all members of the TNF superfamily activate NF-kB, which can suppress apoptosis.

TNFR1 Signaling Pathway (TNFR1), TNFR2 Signaling Pathway (TNFR2), TNF/Stress
Related Signaling (Stress), FAS Signaling Pathway (CD95) and Death Pathway are
pathways activated by members of the Tumor necrosis factor (TNF) super-family. The
ligands, receptors and biological functions of these pathways can be found in Table 3.
Pathway
TNFR1
TNFR2
TNF
Fas
Death
Death

Ligand
TNF-α
TNF-β
TNF-α
FasL
VEGI
TRAIL

Receptor
TNFR1
TNFR2
TNFR1
Fas
DR3
DR4, DR5

Induction of Apoptosis
Yes
Yes
Yes
Yes
Yes
Yes

Induction of NF-kB
Yes
Yes
Yes
Yes
Yes
Yes

Table 3. Ligand, receptor and biological functions of TNF superfamily related pathways
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TNF

Mitochondria

TNFR

l

TRAF-2
TRADD

RIP

Cytochrome C
FAS

FADD
IKK
FLICE

Apaf-1

CASP 9

Apoptosis

NF-kB

Figure 9. TNF signaling pathways leading to apoptosis and NF-kB

Note that these pathways function upstream for the activation of apoptosis, NF-kB, or
both. The underlying mechanisms for the induction of apoptosis and NF-kB by the TNF
superfamily related pathways will be discussed next and a graph that simplifies the whole
process can be found in figure 9.

There are two types of TNF receptors: those that have a death domain (DD) in their
cytoplasmic portion and those do not have a DD. TNFR1, Fas, DR3, DR4 and DR5
contain a DD and belong to the first type. They can lead to apoptosis by recruiting their
DD with FADD and FLICE. TNFR1 induce apoptosis in slightly different way since its
DD recruits TRADD first before the recruitment of FADD and FLICE. Apoptosis might
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also be induced by the TNF family through mitochondrial dependent intrinsic pathways
shown in Figure 9. TNFR2 does not have a DD and thus belongs to the second type. It
has been shown that TNFR2 is still be able to mediate apoptosis through a DD
independent way, the specific mechanism of which remains to be revealed (Ramesh et
al.,2003; Haridas et al.,1998) [25,26].

NF-kB can be activated by all members of the TNF superfamily and this is mediated by a
family of adaptors called tumor necrosis factor receptor associated factors (TRAFs) [27].
TNFRs associate with TRAFs through a conserved cytoplasmic motif termed TRAFinteracting motifs (TIMs). Receptor-interacting protein (RIP) is then recruited and this
leads to the phosphorylation of IkB protein by IKK kinases and NF-kB activation.
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4.4 T-cell Differentiation

Naive T Cell
IL-12,IFN-γ

IL-4

Th1

Th2

IL-2

IL-4, IL-5

Protection from

Protection from

intracellular pathogens

extracellular pathogens

Figure 10. T-cell polarization
T cells, also known as lymphocytes, are a type of white blood cells that play an important
role in adaptive immunity. Based on biological functions, T cells can be divided into
several subsets such as T helper cells, cytotoxic T cells, memory T cells and natural killer
T cells. T helper cells (Th cells) which assist in the immune response by secretion of
small signaling protein molecules such as cytokines, can be differentiated into two major
subgroups: T helper subset 1 cells (Th1) and T helper subset 2 cells (Th2).
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Polarization of T helper cells depends largely on the type of cytokines during priming
(See Figure 10). For instance, IL-12 and IFN- γ facilitate polarization of Th1 cells
whereas IL-4 tend to promote differentiation of Th2 cells [36]. The two different types of
cells are responsible for the protection against different pathogens. Th1 cells secrete IL-2
and provide protection for the host from intracellular pathogens. On the other hand, Th2
cells which secrete IL-4 and IL-5, are involved in the protection against extracellular
pathogens [36].

Pathways such as IL12 and IL2 are up-regulated in old mice, indicating Th1 polarization
is more likely than Th2 polarization in this case. Interestingly, for the analysis of young
mice versus old mice, most of the pathways seem to be involved in innate immunity
whereas for the analysis of middle-aged mice versus old mice, pathways are more
connected to adaptive immunity. This is reasonable since innate immunity is activated
before the adaptive immunity. Furthermore, activation of innate immunity is also
required to activate adaptive immunity.
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4.5 P53, Cell Cycle Arrest and Apoptosis

P38MAPK

ATM

P53
Cell Senescence

G1/S, G2/M

Mitochondria

Cell Cycle Arrest
Fas, DR4/5

FADD

Cytochrome C

Apaf-1

Casp 9
Casp 8

Casp 3

Apoptosis

Figure 11. p53 pathway activate apoptosis, cell cycle arrest and cell senescence
The p53 signaling pathway can be activated in response to both intrinsic and extrinsic
stresses such as DNA damage, hypoxia and oncogenic stimulation within cells [28,29].
Upon activation of the p53 pathway, cells have to choose to follow one of the three
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pathways: cell cycle arrest, cell senescence or apoptosis [28]. Which one of the three
programs is initiated within cells depends on a wide variety of factors, ranging from the
nature of the stress signal, the types and location of the protein modifications on the p53
protein, to the pattern of gene expression in the specific tissue [28]. A graph that
simplifies mediation of the p53 signaling pathway can be found in figure 11.

Ataxia telangiectasia mutated (ATM) has been reported to act upstream of p53 signaling
pathways in an ionizing radiation initiated signal transduction study (Canman et al., 1998)
[30]. In response to DNA damage, p53 is phosphorylated by ATM kinase, leading to the
activation of downstream genes that regulate cell cycle checkpoints or apoptosis [31].
P38MAPK, another activator of p53, has been shown to be able to strengthen p53 activity,
leading to cell cycle arrest or apoptosis (Takekawa et al, 2000) [32].

The p53 signaling pathways mediate apoptosis through both extrinsic and intrinsic
pathways. Intrinsic apoptosis pathways are promoted when p53 interacts with
mitochondria, up-regulating reactive oxygen species (ROS) and pro-apoptotic genes such
as BCL2-associated X protein (BAX), p53 up-regulated modulator of apoptosis (PUMA)
[33]. This results in cytochrome c release and activation of intrinsic apoptosis pathways.
Extrinsic pathways of apoptosis are also mediated by p53. Death receptors such as
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Fas/CD95 and DR5 are activated by p53 and this leads to the activation of extrinsic
pathway of apoptosis [34].

Cells may arrest at cycle checkpoint to allow time for damage repair when exposed to
genotoxic stress. In case that the damage is too severe to be repaired, the cell will
undergo apoptosis. It is a protective mechanism that prevents further cellular damage. At
least two checkpoints have been found: one at G1/S and the other at G2/M [35]. G1/S
prevents damaged DNA from replication whereas G2/M is inhibited by damaged
replicated DNA [35]. Evidence shows that p53 plays an important role in the G1
checkpoint since it is required for the activation of G1/S transition (Kastan, et al., 1991;
Kuerbitz et al.,1992). P53 might be also involved in G2/M transition although it is not
required.

4.6 Differences Between Brain and Cochlear Pathways
As discussed previously, one factor that might affect a cell’s decision to undergo cell
cycle arrest versus apoptosis is the cell type involved. Cells from different tissues might
have different fates even in response to the same kind of stress signal. Thus, it is not
surprising that pathways which are significantly up-regulated in old mice for brain tissue
of the central auditory system are different from that for cochlear tissue samples. It seems
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that up-regulated pathways in old mice for the cochlea such as TNFR1, TNFR2, STRESS,
FAS and DEATH are well studied pathways leading to apoptosis. This might be evidence
indicating cochlea cells undergo apoptosis involving cellular pathways common to other
aging neural system. For brain, pathways such as G1, G2 and RACCYCD are
significantly up-regulated in old mice. This might implicate the involvement of old brain
cells in cell cycle arrest. However, it is not known whether this is due to tissue specificity
or other, yet unidentified differences between the aging cochlea and aging auditory
midbrain. Further experiments need to be conducted to sort out competing hypotheses.
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5. Conclusions
GSEA is a powerful tool that allows us to analyze microarray data at the level of gene
sets. This helps us to interpret results in a biologically meaningful way rather than
struggling with a long list of genes that are up- or down-regulated with age or hearing
loss, without unifying themes or biologically-relevant ways to categorize the data.

Results of the present study are in accordance with those of a previous study (Tadros et
al., 2008), increasing the reliability of the current findings. For instance, genes that
showed significant expression differences for the cochlea samples of all the subject
groups such as members of TNF and TNF receptor family, Caspase family members and
NF-kB related genes, are also important components of pathways which are implicated to
be up-regulated in old mice, as previously discovered by Tadros et al. using different
biostatistical data analysis approaches.

For the cochlea, most of the pathways identified in the present investigation seem to
induce apoptosis and/or immune responses. Pathways regulating innate immunity seems
to be significantly different for the analysis of young mice versus old mice, whereas
pathways regulating adaptive immunity are significantly different for the analysis of
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middle-aged mice versus old mice. This is in consistent with the fact that, across the
lifespan, activation of innate immunity is required before the activation of adaptive
immunity. Differences between results for the brain and cochlea may indicate tissue
specificity concerning cell fate. It seems that cochlea cells are more likely to undergo
apoptosis whereas brain cells tend to undergo cell cycle arrest; however, further
experimentation needs to be conducted to verify this hypothesis.
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6. Future Works
Pathways that induce apoptosis and NF-kB are both found to be significantly upregulated with aging/hearing loss. Thus, it is quite possible that there is a balance
between apoptosis and inflammation. How this balance is maintained might be crucial for
the understanding of mechanisms of age-related hearing loss, for both the inner ear and
central auditory system.

Since apoptosis pathways might play an important role in age-related hearing loss,
inhibition of apoptosis might be a potential way to prevent or treat age-related hearing
loss. However, this is limited by its harmful side effects since apoptosis is crucial for the
maintenance of proper function of the organism, i.e., preventing oncogenesis. Thus, it is
important to find the specific targets for age-related hearing loss that can lead to the
discovery of effective therapies for this disease.

In the short term, future work could focus on the construction of genetic regulatory
networks for apoptosis pathways using statistical methods such as Boolean Networks and
Bayesian Networks. This might provide us deeper insights into interactions between
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apoptosis related genes and their roles in the development and progression of age-related
hearing loss.

Another research direction could be the comparison of regulation of pathways between
brain and cochlea. It is expected that differences in regulation of pathways between brain
and cochlea exist due to tissue specificity and cell type differences in these two levels of
the mammalian auditory system. Results of such an investigation would reveal that cells
in the cochlea and brain might have different fates. Cochlea cells are more likely to
undergo apoptosis whereas brain cells, might choose to undergo cell cycle arrest, as
suggested, by the present study. Understanding of this tissue specificity might help us to
find biomarkers and potentially therapeutic agents, that when their pathways are blocked,
they can specifically inhibit apoptosis in the cochlea without affecting other tissues.
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Appendix: Leading edge analysis
This appendix lists the complete result of leading edge analysis.
Gene
Number of Gene Sets
MAP3K1
8
JUN
7
CHUK
6
TRADD
4
FOS
3
NFKB1
2
CRADD
2
PAK1
2
LTA
2
RB1
2
MAP3K14
2
IL1R1
2
TNFRSF1B
2
TRAF6
2
PIK3R1
2
ARHGDIB
2
CFLAR
2
PTPRC
2
TOLLIP
1
TIRAP
1
TLR3
1
TGFB2
1
CASP6
1
CASP3
1
CASP7
1
CASP8
1
IL1RAP
1
IL1B
1
IL1A
1
MAP2K6
1
ACTA1
1
CYCS
1
MAPK8
1
TRAF1
1
BID
1
TRAF2
1
MAP3K7IP2
1
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PXN
1
ATF1
1
BCL2
1
IL6
1
CEBPB
1
IL1RN
1
GAS2
1
BIRC4
1
BIRC3
1
TNFSF10
1
DUSP1
1
RAP1A
1
APAF1
1
IKBKB
1
CD14
1
Table 4. The result of leading edge analysis for the ten gene sets that are up-regulated in
old mice for the GSEA analysis young mice versus old mice from cochlea samples.

Gene
FOS
JUN
MAPK3
PIK3R1
JAK3
CXCR3
IFNG
IL12A
IL12B
IL12RB2
IL18R1
STAT3
MAP3K7
MYC
IFNGR1
F11
IRAK1
F12
CD3G
F10
CD3D
ACTA1
SOCS3

Number of Gene Sets
7
7
5
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
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LY96
1
RELA
1
F8
1
F9
1
SERPING1
1
CCR7
1
F5
1
CCR3
1
F2
1
LCK
1
CCR2
1
PROS1
1
CCL3
1
CCR1
1
BCL2L1
1
PXN
1
MAP3K7IP2
1
PTK2
1
FGA
1
PTK2B
1
KLKB1
1
BCL2
1
MAP3K1
1
SERPINC1
1
COL4A3
1
COL4A2
1
CEBPB
1
COL4A1
1
CBL
1
BAD
1
COL4A6
1
COL4A5
1
RAP1A
1
EPOR
1
CD14
1
Table 5. The result of leading edge analysis for the ten gene sets that are up-regulated in
old mice for the GSEA analysis middle-aged mice versus old mice from cochlea samples.
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Gene
Number of Gene Sets
CDKN1A
6
ATM
5
TGFB2
4
GADD45A
4
NFKBIA
3
RELA
3
CHEK2
2
MAP3K7
2
PIK3R1
2
PTPRC
2
CSF2
2
CCL3
1
MEF2A
1
KLRC3
1
IL18
1
CCR1
1
ELK1
1
ITGB1
1
CCL4
1
B2M
1
CDKN2D
1
IL4R
1
IL1RAP
1
IFNG
1
CD4
1
IL18R1
1
TGFBR1
1
STAT1
1
LAT
1
CCR5
1
CCR4
1
MAPK3
1
CCR2
1
KLRC1
1
Table 6. The result of leading edge analysis for the twelve gene sets that are up-regulated
in old mice for the GSEA analysis young mice versus old mice from brain samples.
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